From Point72 to Credit Suisse, Wall Street is on the Hunt for Medical and Bioscience Experts to Get Ahead on the Healthcare Investing Boom (Business Insider)
Steven Cohen‘s Point72 is scouting for people with healthcare degrees to join its analyst program. Marshall Wace is also looking for healthcare experts for its summer MBA internship program in June. Credit Suisse wants life sciences and biotechnology experts for its summer analyst program. After spending years – and likely hundreds of thousands of dollars – on doctor of medicine degree, most recent medical school grads are looking to become doctors.
Hedge Fund Giant Ray Dalio Says Financial Markets Shifting, Crypto ‘Vulnerable’ to Government Crackdown (Daily Hodl)
Veteran hedge fund manager Ray Dalio says that financial markets are shifting into a new era as crypto assets may become more vulnerable to government regulations. In a new interview on The David Rubenstein Show, the billionaire says that the days of “cheap money” are ending as the Federal Reserve loses the ability to create money without triggering noticeable inflation.
Moorfield Makes First Investment in Co-Living Scheme (Showhouse.co.uk)
Moorfield Group, the UK-focused real estate fund manager, on behalf of its Moorfield Real Estate Fund IV, has agreed to forward fund an 81 bed best-in-class co-living scheme near Ealing Broadway, West London, for £21 million. It represents Moorfield’s entry into the fast-growing London co-living sector, which is expected to be a beneficiary of demand from young professionals looking for affordable, high quality and flexible accommodation.
Monday 2/7 Insider Buying Report: BST, GRNA (Nasdaq.com)
On Wednesday, Blackrock Science and Technology’s, Tony Kim, made a $778,104 buy of BST, purchasing 16,750 shares at a cost of $46.45 each. Bargain hunters have the opportunity to pick up BST at a price even lower than Kim did, with shares trading as low as $45.25 in trading on Monday — that’s 2.6% under Kim’s purchase price. Blackrock Science and Technology Trusthar is trading up about 1.2% on the day Monday. This buy marks the first one filed by Kim in the past twelve months. And also on Wednesday, Director Ganesh Kishore purchased $750,000 worth of GreenLight Biosciences Holdings, purchasing 75,000 shares at a cost of $10.00 a piece. GreenLight Biosciences Holdings is trading off about 6% on the day Monday. Investors can bag GRNA even cheaper than Kishore did, with shares trading as low as $8.10 at last check today — that’s 19.0% under Kishore’s purchase price.
Moderna And 4 Other Stocks Sold By Insiders (Benzinga)
Public Service Enterprise Group: The Trade: Public Service Enterprise Group Incorporated PEG Chairman, President and CEO Ralph Izzo disposed a total of 9,883 shares at an average price of $66.15. The insider received $653.78 thousand as a result of the transaction. Moderna: The Trade: Moderna, Inc. MRNA CEO Stephane Bancel sold a total of 23,000 shares at an average price of $167.79. The insider received $3.19 million from selling those shares. Alcoa: The Trade: Alcoa Corporation AA EVP and Gen. Counsel Jeffrey D Heeter sold a total of 17,696 shares at an average price of $60.56. The insider received $1.07 million as a result of the transaction. Schlumberger: The Trade: Schlumberger Limited SLB VP, Director Tax Pierre Chereque sold a total of 8249 shares at an average price of $39.31. The insider received $324.27 thousand from selling those shares.
